http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104278013-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate | 2013-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104278013-B |
| titleOfInvention | Anti-human tissue transglutaminase 2 monoclonal antibody and application thereof |
| abstract | The invention discloses an anti-human tissue transglutaminase 2 monoclonal antibody and application thereof. A rat hybridoma cell strain, particularly rat anti-human tissue transglutaminase 2 (tGM2) hybridoma cell XK-1 (CCTCC NO:C201312), is established. The hybridoma cell secretes an anti-human tissue transglutaminase 2 (tGM2) monoclonal antibody; and the monoclonal antibody protein has a specific inhibition action on tissue transglutaminase 2 (tGM2), is capable of effectively inhibiting enzyme activity of mouse tGM2 and restoring activity of matrix metal proteinases (MMPs), and has the function of treating liver fibrosis. |
| priorityDate | 2013-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.